ATXI — Avenue Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $0.79m
- -$2.74m
Annual cashflow statement for Avenue Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.15 | -3.73 | -3.6 | -10.5 | -11.7 |
| Non-Cash Items | 0.71 | 0.442 | -4.4 | 1.33 | 2.49 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.172 | -0.461 | 0.408 | -0.29 | 0.179 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -4.61 | -3.75 | -7.6 | -9.45 | -9.03 |
| Other Investing Cash Flow Items | -1 | 0 | — | -3 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1 | 0 | — | -3 | 0 |
| Financing Cash Flow Items | 0 | -0.663 | -0.508 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0 | 4.38 | 10.5 | 7.53 | 9.84 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5.61 | 0.631 | 2.94 | -4.92 | 0.811 |